Fundraising Fox

May Han

Investor

Partner at Cure Ventures

Massachusetts

Writes $100K – $5M checks · typically $1.5M

About

Partner with over 20 years in drug discovery and development across small molecules, biologics and cell therapies, with deep expertise in oncology and metabolic diseases. Previously held leadership roles at Novartis, AVEO and Millennium Pharmaceuticals.

Contact· self-published, not guessed

Experience

  1. Cure VenturesPartnercurrent2021 — presentGreater Boston
  2. NovartisDirector, Project Management2013 — 2021
  3. AVEO OncologyProgram Leader2012 — 2013
  4. AVEO OncologyDirector of Preclinical Development2003 — 2012
  5. Millennium Pharmaceuticals Inc.Scientist II2000 — 2003
  6. Yale UniversityPostdoc1997 — 2000
  7. Rockefeller UniversityGraduate student and Postdoc1993 — 1997

Colleagues at Cure Ventures

Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures

Network3

Bill Amsbaugh
CTO and Partner at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Drew King
CFO and Partner at Cure Ventures

Investors connected to May in public investor directories — a warm-intro map.

Frequently asked questions

Who is May Han?
Partner with over 20 years in drug discovery and development across small molecules, biologics and cell therapies, with deep expertise in oncology and metabolic diseases. Previously held leadership roles at Novartis, AVEO and Millennium Pharmaceuticals.
Where does May Han work?
May Han is Partner at Cure Ventures.
What check size does May Han write?
May Han typically writes checks of $100K – $5M.
Where did May Han go to school?
May Han studied at Yale University (Ph.D., Biophysics and Biochemistry); Peking University (BS, Biochemistry).

Same school

Also attended Yale University651

Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorBen SilbermannCo-founder of PinterestZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)

+ 645 more

Also attended Peking University143

Erica WuInvestment Director at Intel CapitalGiuseppe IademarcoHead of Global Partnership at P101 VenturesLucy BradyHead of Product at Giant Ventures Global LlpLuke TangManaging Partner at G Vision CapitalJonathan BarekChief Operating Officer at Next47Raaj RayatPrincipal at AirTree Ventures

+ 137 more

Shared employers

Also worked at Novartis130

Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures

+ 124 more

Also worked at AVEO Oncology2

Jeno GyurisPartner at Cure VenturesRaju KucherlapatiVenture Partner at Catalio Capital Management, LP

Also worked at Millennium Pharmaceuticals Inc.3

Abbie CelnikerInvestor at Third Rock VenturesCraig MuirInvestor at Third Rock VenturesDave DeLuciaFounder & Director at Cascador

Also worked at Yale University119

Ann Miura-KoCo-founding Partner at FloodgateStacey HeroInvestor at Third Rock VenturesVivek GopalanInvestment Team at 8VCSallie KimInvestor at 8VCPaul CoyerVenture Partner at IronGate Capital AdvisorsMax WebsterFounder at Hivemind Ventures, Llc

+ 113 more